PG

Business Context and Reporting Period

Company: The Procter & Gamble Company (P&G)
Filing Type: Form 10-Q (Quarterly Report)
Reporting Period: Three months ended September 30, 2025 (Fiscal Q1 2026)
Business Overview: P&G is a global leader in fast-moving consumer goods, operating across five reportable segments: Beauty, Grooming, Health Care, Fabric & Home Care, and Baby, Feminine & Family Care. The company sells products in approximately 180 countries.

Key Financial Metrics

Note: Total Debt calculated as Debt due within one year ($11,631) + Long-term debt ($24,315).

Material Changes vs. Prior Period

• Revenue Growth: Net sales increased 3% ($649 million) driven by higher pricing (1%), favorable mix (1%), and favorable foreign exchange (1%). Organic sales grew 2%.
• Profitability Surge: Net earnings increased 20% ($794 million). This significant jump is primarily attributable to a non-cash charge of approximately $752 million in the prior year (Q1 2024) related to the liquidation of operations in Argentina, which depressed the prior year's earnings.
• Margin Compression: Gross margin decreased 70 basis points to 51.4% due to unfavorable product mix, product/packaging investments, tariffs (60 bps), and higher commodity costs. These were partially offset by manufacturing productivity savings (140 bps) and higher pricing (50 bps).
• Segment Performance:
  • Beauty: Sales +6%, Earnings +5%.
  • Grooming: Sales +5%, Earnings +9%.
  • Health Care: Sales +2%, Earnings -3%.
  • Fabric & Home Care: Sales +1%, Earnings -3%.
  • Baby, Feminine & Family Care: Sales +1%, Earnings +4%.
• Restructuring: The company incurred $215 million in restructuring charges in Q1 2025 related to a new portfolio and productivity plan announced in June 2025.

Guidance, Outlook, and Risks

• Restructuring Plan: P&G expects to incur $1.5 to $2.0 billion in before-tax restructuring costs over two years (fiscal 2026-2027), including a reduction of up to 7,000 non-manufacturing overhead personnel. Half of these costs are expected by the end of fiscal 2026.
• Share Repurchases: The company reaffirmed an expectation to repurchase approximately $5 billion of shares in fiscal 2026. In Q1 2025, they repurchased 8.0 million shares for $1.25 billion.
• Dividends: Dividends paid were $2.55 billion in Q1 2025.
• Key Risks:
  • Foreign Exchange: Significant exposure to currency fluctuations, particularly devaluation of foreign currencies against the U.S. dollar.
  • Commodity Costs: Volatility in oil-derived materials (resins) and paper-based materials (pulp).
  • Geopolitical: Ongoing war between Russia and Ukraine (Russia accounts for ~1% of sales) and global trade tensions.
  • Impairment Risk: The Gillette indefinite-lived intangible asset ($12.8 billion carrying value) is sensitive to changes in growth rates, discount rates, and royalty rates.
• Non-GAAP Measures: Core EPS (excluding incremental restructuring) was $1.99, representing a 3% increase year-over-year, compared to the 21% increase in GAAP Diluted EPS.

Investor Verification Checklist

• Argentina Liquidation Impact: Verify the specific non-cash charges recorded in Q1 2024 to understand the baseline for the 20% earnings growth in Q1 2025.
• Restructuring Execution: Monitor the pace of the $1.5–$2.0 billion restructuring plan and the associated headcount reductions (up to 7,000) to assess future cost savings.
• Gillette Valuation: Review the sensitivity analysis for the Gillette intangible asset, as adverse macroeconomic changes could trigger impairment charges.
• Organic Sales Drivers: Confirm the sustainability of the 2% organic sales growth, noting that volume was neutral and growth was driven by pricing and mix.
• Debt Maturity Profile: Review the schedule of debt maturities given the current interest rate environment and the company's reliance on refinancing.